Effect of BG Versus RI on the Depth of WSL

August 13, 2026 updated by: Riphah International University

Effect of Bioactive Glass Versus Resin Infiltration (ICON) on the Depth of White Spot Lesions: An in Vitro Study

The aim of this in vitro study is to assess the mean lesion depth improvement and hardness of artificial white spot lesions by comparing the effects of bioactive glass toothpaste and resin infiltration (ICON).

Study Overview

Detailed Description

White spot lesions are an adverse result of orthodontic treatment caused by poor oral hygiene. It is difficult to maintain oral hygiene during fixed orthodontic treatment.White spot lesions are subsurface enamel porosities due to demineralization of enamel. They are basically the early stages of caries and has milky white appearance. WSLs are usually formed four weeks after bracket placement.There are various methods for the treatment of white spot lesions. The invasive methods include crowns or veneers and microabrasion. The non-invasive methods are remineralizing agents like topical fluoride, bioactive glass, GC Tooth Mousse and resin infiltration material (ICON). Fluoride compounds are one of the first therapies for WSL. Fluoride varnishes inhibit the demineralization process and promotes the remineralization of enamel. The fluoride varnish forms the calcium fluoride on enamel surface and prolong the contact between fluoride and enamel.Previous studies have shown promising results achieved by bioactive glass as compared to other remineralizing agents. Resin infiltration has been introduced recently and there are few studies on the treatment of WSLs. The rationale of the study is to compare the effects of bioactive glass and resin infiltration through scanning electron microscopy and microhardness, as there is limited research on this topic. The purpose of this study is to compare and evaluate the lesion depth of artificial white spot lesions before and after the treatment with sodium fluoride varnish, bioactive glass and resin infiltration (ICON). The null hypothesis is that there are no significant differences among the three groups for the treatment of white spot lesions.

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Upper and lower premolars will be collected from patients undergoing extractions.

    • The teeth should be healthy with no carious lesions.
    • The crown and root morphology of teeth should be normal.
    • The extracted premolar teeth of patients should have no history of previous dental treatment.

Exclusion Criteria:

  • • Fractured premolars due to any cause.

    • Loss of enamel due to parafunctional habits.
    • Presence of enamel anomalies (amelogenesis imperfecta, hypoplasia etc.).
    • Presence of stains, demineralization, decay, fluorosis and restorations

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Bioactive glass
toothpaste for white spot lesions

A carbonated beverage (Coca Cola, Pakistan ltd) will be used for artificial white spot lesion formation. The pH of the beverage will be 4-4.5 at 37ºC. The teeth will be immersed in demineralization solution for 4 weeks before treatment. The solution will be changed every 48 hrs. to keep the pH constant.

After demineralization specimens will be washed with distilled deionized water (DDW). The tooth will have a white spot lesion only on the buccal surface.

A sufficient amount of 5% bioactive glass (Biomin F T/P) was applied on the tooth surface for three minutes using a tooth brush. The toothpaste remained on the surface for an additional 30 minutes.

Active Comparator: Resin Infiltration(ICON)
Infiltration on the tooth surface to treat white spot lesions

A carbonated beverage (Coca Cola, Pakistan ltd) was used for artificial white spot lesion formation. The pH of the beverage was 4-4.5 at 37ºC. The teeth were be immersed in demineralization solution for 4 weeks before treatment. The solution was changed every 48 hrs. to keep the pH constant.

After demineralization specimens were washed with distilled deionized water (DDW). The tooth would have a white spot lesion only on the buccal surface.

Resin infiltration (ICON) infiltration will be applied according to manufacture as following:

  • Application of Icon Etch (15% HCL gel) for 2 minutes.
  • Water rinsing and air drying for 30 sec.
  • Application of Icon-dry (ethanol) for 30 sec.
  • Air drying
  • Application of Icon Infiltrant for 3 minutes.
  • Light curing for 40 seconds.
Placebo Comparator: Fluoride toothpaste
Fluoride content treats the white spot lesion

A carbonated beverage (Coca Cola, Pakistan ltd) was used for artificial white spot lesion formation. The pH of the beverage will be 4-4.5 at 37ºC. The teeth were immersed in demineralization solution for 4 weeks before treatment. The solution was changed every 48 hrs. to keep the pH constant.

After demineralization specimens was washed with distilled deionized water (DDW). The tooth would have a white spot lesion only on the buccal surface.

The teeth were cleaned and dried first. 5% Sodium fluoride (Enamelist) varnish was applied on tooth surface with disposable tooth brush. The varnish remained undisturbed on teeth for 4 hours.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Scanning Electron Microscopy
Time Frame: 4th week
Changes in baseline lesion depth were assessed using scanning electron microscopy. Scanning electron microscopy is used to assess lesion depth before and after treatment with remineralizing agents. Lesion depth is measured in microns. Comparison is made by calculating the average depth of treated samples against untreated demineralized control samples.
4th week
Vickers Microhardness Test
Time Frame: 4th week
Changes from baseline microhardness tests are used to measure changes in surface hardness before and after remineralization. Sound or artificially demineralized enamel (acid-etched or caries-like lesions) is tested first to set a control value. Agents like fluoride varnishes, CPP-ACP (Casein Phosphopeptide-Amorphous Calcium Phosphate), or bioactive glass are applied over cycles. The percentage surface hardness measures how much demineralized enamel is hardened after remineralization treatment relative to original healthy baseline.
4th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ulfat Bashir, MDS, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

March 30, 2027

Study Registration Dates

First Submitted

August 13, 2026

First Submitted That Met QC Criteria

August 13, 2026

First Posted (Actual)

August 18, 2026

Study Record Updates

Last Update Posted (Actual)

August 18, 2026

Last Update Submitted That Met QC Criteria

August 13, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IIDC/IRC/2024 Ayesha Islam

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe